Methotrexate from Canada
Methotrexate is a folic acid antagonist containing pteridine heterocyclic rings, used as an antineoplastic and immunosuppressant drug. Classified under HTS 2934.99.4700 as a pharmaceutical drug with 'other heterocyclic compounds' structure. Its complex ring system with multiple nitrogens defines its Chapter 29 placement.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.6096.3%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Submit FDA IND/NDA documentation for API import; maintain GMP-certified supply chain; beware reclassification risk if purity <99% suggesting intermediate status